Lmst

Today, on #WorldCancerDay, we honor the groundbreaking work of BMIA 2025 laureates Prof. Carl June & Prof. Michel Sadelain, whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment.

#cancer #cancercure #cancertreatment #cartcell #immunotherapy

Today, on hashtag#WorldCancerDay 2026, we honor the groundbreaking work of BMIA 2025 laureates Prof. Carl June (University of Pennsylvania) & Prof. Michel Sadelain (Columbia University Department of Medicine), whose pioneering research in CAR-T cell therapy has revolutionized cancer treatment.

By harnessing the power of a patient’s own immune system, their therapies have transformed outcomes for patients with previously untreatable blood cancers, turning life-threatening diagnoses into stories of hope and survival.
Their work demonstrates the profound impact of innovation and translational research in medicine, showing how bold scientific discoveries can move from the lab to the clinic & save lives.

Do you know an outstanding scientist whose work is shaping the future of medicine? Nominate them for the Broermann Medical Innovation Award 2026 by March 1!

#cancer #cancercure #cancertreatment #cartcell #immunotherapy

New lung cancer research insights 🎥

In this expert roundtable led by Dr. @jennifermarksmd, Dr. Elliot Brea shares ASCO 2025 updates on emerging cellular therapies, including CAR T-cell therapy, for NSCLC and SCLC—explained clearly and concisely.

Watch the full video: https://youtu.be/hLy10mitvG8

#LungCancer #ASCO2025 #CellularTherapy #CARTCell #CancerEducation

Indications for CAR-T Cell Therapy presented by Dr. @amarkelkar!

Join us here: https://give.cancergrace.org/event/2025-blood-cancers-onctalk/e715673

#BloodCancer #Cancer #cancerGRACE #CARTCell #Lymphoma

Now presenting Dr. @amarkelkar: "The Future of Medicine is Now: Emerging Cell Therapies"

#BloodCancersOncTalk #CellTherapies #CarTCell #BloodCancerEducation

📢 It's the last day of #WorldBloodCancerAwarenessMonth!
⚡Join us tomorrow, Oct 1 at 10:30 CET for our Impact on Blood Cancer event & find out how our projects are leveraging #RealWorldData #BigData to improve patient outcomes & improving #CARTCell capabilities.
👉 REGISTER HERE: https://link.europa.eu/hdYgBh

Join us for Impact on Blood Cancer at 10:30 on 1 October

🩸 From mining #BigData to advancing #CarTCell therapies, IMI and IHI projects are working hard to improve the lives of people living with #BloodCancers like leukaemia.

👉 Find out more about their achievements and plans at our online event on 1 October - sign up now at https://europa.eu/!hdYgBh

#IHITransformingHealth #HorizonEU

Impact on Blood Cancer
01.10.2025
10:30 CET
Online event
Registration now open
Meet the speakers
Michael Hudecek, University Hospital Würzburg
Jesús María Hernandez, University Hospital of Salamanca and ISBAL
Sonja Steppan, Fresenius SE & Co, KGaA
Lars Bullinger, Charité Universitätsmedizin Berlin
Oussama Karroum, Innovative Health Initiative

🩸 How can we improve outcomes for people with #BloodCancers?
🚀 Leveraging #BigData, #AI and #CARTCell therapies, our projects are delivering important results for patients.
👩‍💻 Join us online on 1 October, 10:30–12:00 CET for “Impact on Blood Cancers” and find out more!
👩‍🔬 Featuring leading experts from the HARMONY Alliance Foundation, T2EVOLVE & EASYGEN Consortium
🎟️ Register now 👉 https://europa.eu/!hdYgBh

#BloodCancer #BigDataInHealth #IHITransformingHealth #CellTherapy

Impact on Blood Cancer
Leveraging big data and CAR-T therapies to improve outcomes for patients
10:30-12:00 CET
01.10.2025

🩸 How can we improve outcomes for people with #BloodCancers?
🚀 Leveraging #BigData, #AI and #CARTCell therapies, our projects are delivering results.
👩‍💻 Join us online on 1 Oct 10:30–12:00 CET & find out more!
https://europa.eu/!hdYgBh
#BigDataInHealth #IHITransformingHealth

Join us on 1 October at 10:30 to learn more about how IHI and IMI projects are leveraging big data and CAR-T therapies to improve outcomes for patients

Melbourne mother says her medical insurer won’t cover the treatment that could save her life

Melbourne resident Zohreh Sajjad has been diagnosed with an aggressive cancer but her health insurer, Medibank, is refusing…
#NewsBeep #News #Headlines #AU #Australia #Cancer #cancertreatment #cartcell #hosseinmajlesi #immunotherapy #lymphoma #medibank #medicalinsurance #treatment #zohrehsajjad
https://www.newsbeep.com/92249/

Scientists have made major strides in engineering #CARTcell therapies to treat autoimmune disorders such as lupus, according to a 2024 @ScienceTM Review that discusses recent breakthroughs and clinical trials in the field.
Learn more on #WorldLupusDay: https://t.co/gK1hyqtZM9

"Leo Ferreira, Ph.D., assistant professor at MUSC, discusses his research presented in his AACR poster "Repurposing chimeric antigen receptor regulatory T cells for treating cancer." #yt

https://invidious.nerdvpn.de/watch?v=OngSJR9MHZ0

Bckp.:

https://youtu.be/OngSJR9MHZ0

#CARTCell #Therapy #novelmedicine

'Remission rates for patients with some forms of blood cancers treated with CAR T-cell therapy can exceed 80 per cent. But it is certainly not a miracle treatment for all forms of cancer. Biology is messy, the quality of cell therapies variable and the treatment does not work on all patients. And, despite its life-saving promise, cell therapy suffers one additional serious drawback: its cost. Emily’s cell therapy cost $473,000, putting it beyond the reach of all but the richest or best-insured. Thousands of patients who could be cured of various diseases are dying because of supply constraints. “Science is outstripping our ability to manufacture,” says June.'
#Immunology #Immunotherapy #CARTcell
https://www.ft.com/content/626007c4-9127-4682-9dab-154b32434029

BioNTech is partnering with Autolus to develop their #CARTcell program for solid tumors:
https://investors.biontech.de/news-releases/news-release-details/biontech-and-autolus-announce-strategic-car-t-cell-therapy
#Immunology #Immunotherapy

The target antigen of BioNTech SE's BNT211 CART is Claudin-6. I wrote about this in 2022 👇

https://www.nature.com/articles/d41591-022-00091-3

https://www.nature.com/articles/d41586-023-03968-6
wow.
"Engineered immune cells have given 15 people with once-debilitating autoimmune disorders a new lease on life, free from fresh symptoms or treatments…the approach — called #CARTCell therapy — might one day be extended to a variety of other conditions fueled by rogue #immune cells that produce antibodies against the body’s own tissues.

All 15 participants, who each had one of three autoimmune conditions, have remained disease-free or nearly so since their treatment…"